InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 203

Tuesday, 03/08/2011 9:12:03 AM

Tuesday, March 08, 2011 9:12:03 AM

Post# of 392
7:01AM Vanda Pharma receives Orphan Drug designation in Europe for tasimelteon (VNDA) 7.25 : Co announced that the European Commission has granted Orphan Drug designation for tasimelteon, an oral dual melatonin receptor agonist in Phase III clinical trails for Non-24-Hour Sleep/Wake Disorder in blind individuals with no light perception.


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNDA News